SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001278819-04-000057
Filing Date
2004-12-20
Accepted
2004-12-20 10:21:06
Documents
1
Period of Report
2004-11-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3316
  Complete submission text file 0001278819-04-000057.txt   5382
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O NABI BIOPHARMACEUTICALS 5800 PARK OF COMMERCE BLVD NW BOCA RATON FL 33487 5619895800
FAHIM RAAFAT E F (Reporting) CIK: 0001271999 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 041212995